NewGenIVF shares rise 42.10% intraday as company schedules 1-for-3 reverse stock split on January 26th.

NewGenIVF Group surged 42.10% intraday following the announcement of a 1-for-3 reverse stock split scheduled for January 26, 2026, and the appointment of award-winning Web3 leader Joshua Chu to its board. The board approved the reverse split on December 23, 2025, aiming to increase the stock’s per-share value and potentially improve market perception. The executive appointment, highlighting strategic expansion into Web3 technologies, further bolstered investor confidence. These developments aligned with the stock’s sharp intraday rally, as investors likely interpreted the restructuring and leadership move as signals of operational and strategic momentum.